Janux Therapeutics (JANX) Accumulated Depreciation & Amortization (2020 - 2025)
Historic Accumulated Depreciation & Amortization for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to $6.5 million.
- Janux Therapeutics' Accumulated Depreciation & Amortization rose 4627.5% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 4627.5%. This contributed to the annual value of $5.0 million for FY2024, which is 6993.82% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Accumulated Depreciation & Amortization is $6.5 million, which was up 4627.5% from $6.0 million recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $6.5 million in Q3 2025 and a low of $39000.0 during Q2 2021
- Its 5-year average for Accumulated Depreciation & Amortization is $2.5 million, with a median of $2.1 million in 2023.
- In the last 5 years, Janux Therapeutics' Accumulated Depreciation & Amortization surged by 75909.09% in 2022 and then soared by 4627.5% in 2025.
- Quarter analysis of 5 years shows Janux Therapeutics' Accumulated Depreciation & Amortization stood at $131000.0 in 2021, then skyrocketed by 641.98% to $972000.0 in 2022, then skyrocketed by 199.79% to $2.9 million in 2023, then surged by 69.94% to $5.0 million in 2024, then surged by 31.24% to $6.5 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $6.5 million for Q3 2025, versus $6.0 million for Q2 2025 and $5.5 million for Q1 2025.